| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SMR | Class A Common Stock | Options Exercise | $78,644 | +12,269 | +157% | $6.41 | 20,063 | 13 Feb 2023 | Direct | F1 |
| transaction | SMR | Class A Common Stock | Options Exercise | $37,005 | +5,773 | +29% | $6.41 | 25,836 | 13 Feb 2023 | Direct | F1 |
| transaction | SMR | Class A Common Stock | Options Exercise | $26,827 | +2,815 | +56% | $9.53 | 7,854 | 13 Feb 2023 | Direct |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | SMR | Employee Stock Option (right to buy) | Options Exercise | $0 | -12,269 | -71% | $0.000000 | 5,051 | 13 Feb 2023 | Class A Common Stock | 12,269 | $6.41 | Direct | F2, F3 |
| transaction | SMR | Employee Stock Option (right to buy) | Options Exercise | $0 | -5,773 | -33% | $0.000000 | 11,547 | 13 Feb 2023 | Class A Common Stock | 5,773 | $6.41 | Direct | F2, F4 |
| transaction | SMR | Employee Stock Option (right to buy) | Options Exercise | $0 | -2,815 | -27% | $0.000000 | 7,577 | 13 Feb 2023 | Class A Common Stock | 2,815 | $9.53 | Direct | F5 |
| Id | Content |
|---|---|
| F1 | The number of Acquired Securities and Amount of Securities Beneficially Owned following the transaction were inaccurately reported on Form 4 filed February 15, 2023. |
| F2 | The Number of Derivatives Disposed of and Number of Derivative Securities Beneficially owned following reported transaction were inaccurately reported on Form 4 filed February 15, 2022. |
| F3 | The option became exercisable for 25% of the shares on April 1, 2021, and for 1/48th of the shares at the end of each one-month period thereafter, so that the option will become fully exercisable on April 1, 2024. |
| F4 | The option became exercisable for 25% of the shares on November 1, 2022, and for 1/48th of the shares at the end of each one-month period thereafter, so that the option will become fully exercisable on November 1, 2025. |
| F5 | The option became exercisable for 25% of the shares on January 4, 2023, and for 1/48th of the shares at the end of each one-month period thereafter, so that the option will become fully exercisable on January 4, 2026. |